Distribuzione geografica
Continente #
NA - Nord America 4573
EU - Europa 424
AS - Asia 383
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5383
Nazione #
US - Stati Uniti d'America 4569
CN - Cina 315
DE - Germania 125
FI - Finlandia 89
IT - Italia 74
SE - Svezia 61
VN - Vietnam 56
UA - Ucraina 46
GB - Regno Unito 20
IN - India 7
CA - Canada 4
NL - Olanda 3
FR - Francia 2
KR - Corea 2
AT - Austria 1
AU - Australia 1
EU - Europa 1
GR - Grecia 1
JP - Giappone 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 5383
Città #
Fairfield 890
Woodbridge 760
Houston 408
Cambridge 353
Ashburn 335
Wilmington 323
Ann Arbor 306
Seattle 297
Jacksonville 251
Chandler 181
Princeton 125
Beijing 96
San Diego 84
Nanjing 62
Dong Ket 56
Padova 52
Medford 46
Roxbury 36
Helsinki 34
Des Moines 27
Guangzhou 24
Nanchang 17
Shenyang 16
Hebei 15
Changsha 12
Falls Church 12
Jinan 12
Redwood City 12
Tianjin 12
Norwalk 10
Jiaxing 8
Munich 8
Kunming 5
Ningbo 5
Taizhou 4
Detroit 3
Fuzhou 3
Hefei 3
Lebanon 3
San Francisco 3
Taiyuan 3
Zhengzhou 3
Borås 2
Campodarsego 2
Easton 2
Fort Worth 2
Groningen 2
Haikou 2
Hangzhou 2
Hanover 2
Lanzhou 2
Nürnberg 2
Toronto 2
Xian 2
Assèmini 1
Bologna 1
Buffalo 1
Costa Mesa 1
Duncanville 1
Felgueiras 1
Highland 1
Indiana 1
Kuala Lumpur 1
Las Vegas 1
London 1
Los Angeles 1
Milan 1
New York 1
Orange 1
Osaka 1
Parkville 1
Parma 1
Phoenix 1
Pinehaven 1
Redmond 1
Rockville 1
Simi Valley 1
Thessaloníki 1
Treviso 1
Venezia 1
Vienna 1
Yellow Springs 1
Yenibosna 1
Totale 4968
Nome #
CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity 165
SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy 156
The origin of intermuscular adipose tissue and its pathophysiological implications 145
Clonal characterization of rat muscle satellite cells: proliferation, metabolism and differentiation define an intrinsic heterogeneity. 144
Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs 120
DNA immunization in mice against virus-induced tumor antigens. 116
Characterization of subcutaneous and omental adipose tissue in patients with obesity and with different degrees of glucose impairment 111
A structure-activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme 106
Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area 104
Protein kinase CK2 is involved in adipose tissue insulin signaling and remodeling during obesity and weight loss 104
In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves 101
DNA-based vaccination against tumors expressing the P1A antigen 99
Degeneration and Plasticity of the Optic Pathway in Alström Syndrome. 97
Increased mitochondrial calcium uniporter in adipocytes underlies mitochondrial alterations associated with insulin resistance. 97
Increased adipogenic conversion of muscle satellite cells in obese Zucker rats. 95
The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. 94
Rosiglitazone modifies the adipogenic potential of human muscle satellite cells 92
CTL Analysis for Tumor Vaccines. 89
Do oestrogen receptors play a role in the pathogenesis of HIV-associated lipodystrophy? 88
Alström syndrome is associated with short stature and reduced GH reserve. 88
The progression from obesity to type 2 diabetes in Alström syndrome. 88
ALMS1-Deficient Fibroblasts Over-Express Extra-Cellular Matrix Components, Display Cell Cycle Delay and Are Resistant to Apoptosis. 87
Further lowering of muscle lipid oxidative capacity in obese subjects after biliopancreatic diversion 86
GLUT4 defects in adipose tissue are early signs of metabolic alterations in alms1GT/GT, a mouse model for obesity and insulin resistance 85
Alström Syndrome: Cardiac Magnetic Resonance findings. 82
Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization 82
Adiponectin levels in women with polycystic ovary syndrome 81
Brain involvement in Alström syndrome 81
Effects of octreotide exposure during pregnancy in acromegaly 79
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma 79
Characterization of the IGF system in 15 patients with Alstrom syndrome. 79
Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss 74
CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A. 74
CD45 regulates apoptosis induced by extracellular adenosine triphosphate and cytotoxic T lymphocytes 72
Changes in muscle myostatin expression in obese subjects after weight loss 72
Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance 72
Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. 72
Predicting tumor outcome following cancer vaccination by monitoring quantitative and qualitative CD8(+) T cell parameters 69
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance 69
Alström syndrome is associated with short stature and reduced GH reserve 68
Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy 66
Adipogenic potential of skeletal muscle satellite cells 64
Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity 64
Lipoatrophy Induced by Subcutaneous Insulin Infusion: Ultrastructural Analysis and Gene Expression Profiling 63
Ophthalmic features of cone-rod dystrophy caused by pathogenic variants in the ALMS1 gene 60
Cell biology aspects of alstrom syndrome, a monogenic model of metabolic syndrome 57
Review article: adipocytokines and insulin resistance 56
Regulation of Alstrom syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity 56
DNA immunization in mice against virus-induced tumor antigens 52
Optimization of a DNA vaccination protocol for CTL induction against tumors expressing the weakly immunogenic P1A antigen 50
Syndromic obesity: Clinical implications of a correct diagnosis 50
The Case | Familial occurrence of retinitis pigmentosa, deafness, and nephropathy 48
White adipose tissue expansion in multiple symmetric lipomatosis is associated with upregulation of ck2, akt and erk1/2 48
Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alstrom syndrome. 47
Alström Syndrome: Mutation Spectrum of ALMS1 47
Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach 45
WNT10B mutations in human obesity 43
Functional avidity-driven activation-induced cell death shapes CTL immunodominance. 43
Cancer gene therapy by DNA immunization 42
Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond 40
Antitumors DNA vaccines [Vaccini antitumorali a DNA] 40
Neurocognitive assessment and DNA sequencing expand the phenotype and genotype spectrum of Alström syndrome 39
The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus 35
Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cells 34
"Exploring the role of growth hormone antagonist on adipocytes" 34
Liver Fibrosis and Steatosis in Alstrom Syndrome: A Genetic Model for Metabolic Syndrome 31
The Alstrom syndrome protein, ALMS1, interacts with α-actinin and components of the endosome recycling pathway 30
Monogenic diabetes syndromes: Locus-specific databases for Alström, Wolfram, and Thiamine-responsive megaloblastic anemia 29
Consensus clinical management guidelines for Alström syndrome 29
"UCP1 mRNA expression in human subcutaneous and visceral adipose tissue during the progression from obesity to diabetes" 27
In vitro chronic glycation induces AGEs accumulation reducing insulin stimulated glucose uptake and increasing GLP1R in adipocytes 27
Expression of P2 purinergic receptors in human adipocytes 25
The unique combination of dermatological and ocular phenotypes in Alström syndrome: Severe presentation, early onset and two novel ALMS1 mutations 25
Pituitary morphovolumetric changes in Alström syndrome 25
Edmonton Obesity Staging System: an improvement by cardiopulmonary exercise testing 24
Hypoglycaemia one-year after laparoscopic sleeve gastrectomy: Experience of Padua Bariatric Unit 20
Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity 20
Botulinum G Neurotoxin Cleaves VAMP/Synaptobrevin Isoforms at a Single Ala-Ala Peptide Bond 19
Role of CD45 PTP in CTL-mediated apoptosis 19
Adipogenic progenitors in different organs: Pathophysiological implications 18
The mitochondrial protein Opa1 promotes adipocyte browning that is dependent on urea cycle metabolites 17
ASCs and their role in obesity and metabolic diseases 15
Higher Leptin Concentrations in Patients With Alstrom Syndrome As Compared to BMI-Z Matched Controls Are Suggestive of Ciliopathy-Associated Leptin Resistance 14
Metabolic slowing vanished 5 years after sleeve gastrectomy in patients with obesity and prediabetes/diabetes 2
Totale 5443
Categoria #
all - tutte 7331
article - articoli 6995
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 172
Totale 14498

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018144 0036 2247 00 111522
2018/2019625 13561 110 534 10105210189
2019/20201401 1854742109 138107 134153 1431879462
2020/20211094 421104777 6868 7293 123150105139
2021/20221158 2910113186 6974 70120 8441117236
2022/2023317 188117120 00 00 0000
Totale 5443